Novartis AG (SWX:NOVN)
Switzerland · Delayed Price · Currency is CHF 95.02
+0.30 (0.32%)
Jul 30, 2025, 5:37 PM CET
Novartis AG Market Cap
Novartis AG has a market cap or net worth of 183.94 billion as of July 30, 2025. Its market cap has decreased by -9.20% in one year.
Market Cap
183.94B
Enterprise Value
204.60B
Revenue
43.89B
Ranking
n/a
PE Ratio
17.44
Stock Price
95.02
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has decreased from 186.69B to 183.94B, a decrease of -1.47%. That is a compound annual growth rate of -0.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 183.36B | 3.40% |
| Dec 30, 2024 | 177.34B | 1.66% |
| Dec 29, 2023 | 174.45B | -2.98% |
| Dec 30, 2022 | 179.80B | 0.12% |
| Dec 30, 2021 | 179.59B | -5.61% |
| Dec 30, 2020 | 190.26B | -8.58% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 222.61B |
| Lonza Group AG | 40.05B |
| Alcon | 36.05B |
| Galderma Group AG | 31.93B |
| Sandoz Group AG | 20.29B |
| Straumann Holding AG | 17.44B |
| Sonova Holding AG | 13.92B |
| Ypsomed Holding AG | 5.90B |